Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.36 - $1.78 $171,585 - $848,392
-476,625 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$0.51 - $1.0 $11,362 - $22,279
22,279 Added 4.9%
476,625 $314,000
Q3 2021

Nov 15, 2021

SELL
$3.78 - $5.18 $479,508 - $657,103
-126,854 Reduced 21.83%
454,346 $1.87 Million
Q1 2021

May 17, 2021

BUY
$4.93 - $7.15 $2.87 Million - $4.16 Million
581,200 New
581,200 $2.93 Million

Others Institutions Holding CBIO

# of Institutions
1
Shares Held
215
Call Options Held
0
Put Options Held
0

About CATALYST BIOSCIENCES, INC.


  • Ticker CBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,477,100
  • Description
  • Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...
More about CBIO
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.